stockrow
Friday 6 November 2026
Export SHC’s income statement to Excel — free account
Sotera Health Company
SHC Healthcare Diagnostics & Research
Sotera Health Company’s revenue for fiscal 2025 (year ended December 2025) was $1.2 billion, up 5.74% from fiscal 2024.
- Revenue
- +4.36%
- EPS
- +20.1%
- Free cash flow
- +65.0%
- Total debt
- +0.14%
Quarter to September 2026, against a year earlier
15.87
0.00
0.00%
Follow SHC
Alert me
| Sep '26 | Jun '26 | Mar '26 | Dec '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
30.60 | 31.14 | 34.98 | 65.33 |
+8 more quarters Free account |
P/S ratio |
4.30 | 4.17 | 3.44 | 4.30 | |
P/FCF ratio |
39.05 | 45.01 | 42.18 | 33.58 | |
P/Operating CF |
47.83 | 57.32 | 138.79 | 48.58 | |
P/B ratio |
7.21 | 7.62 | 6.56 | 8.27 | |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Sales |
5.79 | 5.71 | 5.05 | 5.93 | |
EV/EBITDA |
13.25 | 13.10 | 11.69 | 13.68 | |
EV/Operating CF |
21.46 | 23.78 | 22.98 | 24.02 | |
EV/FCF |
52.55 | 61.64 | 61.96 | 46.23 | |
Quick Ratio |
2.57 | 2.23 | 2.21 | 1.98 | |
Current Ratio |
3.13 | 2.80 | 2.82 | 2.46 | |
Net Debt/EBITDA |
12.38 | 13.22 | 17.72 | 13.55 | |
Debt/Assets |
66.15% | 67.47% | 68.96% | 68.48% | |
Debt/Equity |
3.06 | 3.35 | 3.58 | 3.69 | |
Asset Turnover |
0.37 | 0.37 | 0.38 | 0.37 | |
Operating CF/Net income |
1.89 | 1.65 | 1.11 | 2.96 | |
Capex/Depreciation |
(1.55) | (1.33) | (1.43) | (1.49) | |
Interest Coverage |
3.33 | 3.10 | 2.18 | 3.01 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
19.74% | 21.21% | 24.36% | 18.95% | |
Intangible Assets out of Total Assets |
0.40 | 0.41 | 0.43 | 0.43 | |
Share Based Compensation of Revenue |
2.38% | 2.25% | 5.14% | 2.49% | |
Graham Net Nets |
(0.37) | (0.39) | (0.50) | (0.41) | |
Graham Number |
5.90 | 5.47 | 4.49 | 3.60 | |
Earnings Yield |
3.27% | 3.21% | 2.86% | 1.53% | |
Free Cash Flow Yield |
2.56% | 2.22% | 2.37% | 2.98% | |
Revenue per Share |
1.14 | 1.12 | 0.98 | 1.07 | |
Operating CF per Share |
0.39 | 0.31 | 0.10 | 0.36 | |
Capex per Share |
(0.18) | (0.16) | (0.16) | (0.18) | |
Free Cash Flow per Share |
0.20 | 0.15 | (0.06) | 0.18 | |
Cash per Share |
1.44 | 1.25 | 1.11 | 1.22 | |
Shareholders Equity per Share |
2.56 | 2.33 | 2.19 | 2.13 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
2.56 | 2.33 | 2.19 | 2.13 | |
Free Cash Flow |
57.71 | 42.05 | (16.73) | 52.41 | |
Working Capital |
477.34 | 415.22 | 378.17 | 363.83 | |
Capital Expenditures |
(52.83) | (46.45) | (46.17) | (50.70) | |
Net Current Asset Value |
(1,953.13) | (1,994.68) | (2,027.42) | (2,043.74) | |
EV/EBIT |
17.72 | 17.40 | 15.76 | 19.05 | |
Capex to Sales |
0.16 | 0.14 | 0.16 | 0.17 | |
Price to Operating Income |
13.17 | 12.71 | 10.73 | 13.84 | |
| Other line items | |||||
Average Receivables |
158.20 | 153.28 | 138.38 | 147.16 | |
Average Payables |
70.48 | 82.34 | 73.40 | 66.53 | |
Average Inventory |
49.75 | 58.16 | 59.27 | 51.77 | |
Average Assets |
3,286.78 | 3,261.76 | 3,166.71 | 3,167.42 | |
Average Common Equity |
641.86 | 588.47 | 518.30 | 505.47 |
Columns are period end dates · fundamentals updated 5 Nov 2026